// App-Quantinova.ai

1490 : Blockage of TNFα and IL-12/23 Improves Depressive Symptoms in Patients with Psoriatic Arthritis – Analysis of Clinical Trial Data

Researchers

Presenter

  • Alexis Ogdie

Principal Investigators

  • Yujie Zhong

Medical Centers

  • Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada

  • Department of Medicine and Rheumatology and Department of Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

  • School of Statistics and Management, Shanghai University of Finance and Economics, Cambridge, China (People's Republic)

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Interleukin 12

Drug/Treatment

  • Ustekinumab

  • golimumab

  • IL-12

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved